How to Get Vardenafil (Levitra/Staxyn) in Tennessee

At a glance
- Drug class / PDE5 inhibitor approved for erectile dysfunction
- FDA approval year / 2003 (Levitra); 2010 (Staxyn orally disintegrating tablet)
- Telehealth prescribing in Tennessee / Legal and widely available
- Typical starting dose / 10 mg taken 30 to 60 minutes before sexual activity
- Dosing range / 5 mg to 20 mg on demand, not more than once per day
- 503A compounding / Permitted for patient-specific prescriptions from Tennessee-licensed pharmacies
- TennCare (Medicaid) coverage / Not covered for erectile dysfunction (covered for type 2 diabetes mellitus only in limited cases)
- Who can prescribe / MD, DO, NP, PA with prescriptive authority in Tennessee
- Key contraindication / Nitrate medications of any kind (absolute contraindication)
- Time to effect / 30 to 60 minutes; duration up to 4 to 6 hours
What Vardenafil Is and Why Prescribers Choose It
Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor that relaxes smooth muscle in penile vasculature by blocking PDE5-mediated cGMP degradation, allowing increased blood flow during sexual stimulation. The FDA approved the 5 mg, 10 mg, and 20 mg oral tablets under the brand name Levitra in August 2003, and the 10 mg orally disintegrating tablet (Staxyn) in 2010 accessdata.fda.gov.
Clinical Efficacy Data
The landmark Porst et al. Flexible-dose trial (N=580, published in the International Journal of Impotence Research, 2003) found that vardenafil 10 mg and 20 mg produced statistically superior improvements in erectile function domain scores compared with placebo, with 71 to 75 percent of attempts resulting in successful intercourse in the vardenafil arms versus roughly 49 percent for placebo (P<0.001) [1]. That trial included men with diabetes and radical prostatectomy, two populations that historically respond poorly to ED therapy.
A pooled analysis across multiple PDE5 inhibitor studies published on PubMed confirms vardenafil onset as early as 15 minutes in some men, though the labeled recommendation remains 60 minutes before activity [2]. The drug's relatively high selectivity for PDE5 over PDE6 (the retinal isoform) may produce fewer visual disturbances than sildenafil in head-to-head comparisons, though direct superiority data remain limited.
How Vardenafil Compares to Sildenafil and Tadalafil
Vardenafil occupies a specific niche. Sildenafil (Viagra) has the largest post-market dataset. Tadalafil (Cialis) offers a 36-hour window and a daily low-dose option (2.5 to 5 mg). Vardenafil sits between them: a 4-to-6-hour window, on-demand use, and a slightly different interaction profile with CYP3A4 inhibitors [3]. The American Urological Association (AUA) 2018 guideline on erectile dysfunction states that "all three oral PDE5 inhibitors have similar efficacy" and that drug selection should be individualized based on patient preference, comorbidities, and concomitant medications [4].
Tennessee Telehealth Rules for Prescribing Vardenafil
Tennessee law permits a licensed prescriber to evaluate a patient and issue a controlled-substance-exempt prescription via synchronous telemedicine without a prior in-person visit, provided the consultation meets the standard of care. Vardenafil is not a controlled substance, so the prescribing threshold is comparatively straightforward.
What Tennessee Telehealth Law Requires
Under Tennessee Code Annotated 63-1-155 and the Tennessee Board of Medical Examiners' telemedicine rules, a prescriber must:
- Establish a valid patient-provider relationship during the telehealth encounter.
- Collect a sufficient medical history to identify contraindications (particularly nitrate use and cardiovascular status).
- Document the clinical rationale for the prescription.
- Make appropriate follow-up available.
A prescriber does not need to require an in-person physical examination before prescribing vardenafil as long as the telehealth encounter satisfies the standard of care. Multiple national telehealth platforms (including those serving Tennessee) comply with these rules. The FDA's own guidance on telemedicine prescribing acknowledges that audio-video consultations for non-controlled substances are generally sufficient when a prescriber can form a clinical judgment [5].
Synchronous vs. Asynchronous Visits
Tennessee generally requires synchronous (real-time audio-video) encounters for prescribing. Some platforms use a hybrid model: the patient completes a detailed intake form (asynchronous), then the prescriber reviews it and issues the prescription with or without a brief live call. Prescribers should document why a live interaction met the standard of care if no video is used. Patients should confirm the platform they choose uses a Tennessee-licensed prescriber.
Who Can Prescribe Vardenafil in Tennessee
Tennessee grants prescriptive authority to multiple provider types.
Physicians (MD and DO)
Any Tennessee-licensed MD or DO with an active DEA registration can prescribe vardenafil. Primary care physicians, urologists, and men's health specialists all commonly prescribe PDE5 inhibitors. The Tennessee Medical Practice Act governs their scope.
Nurse Practitioners (NPs)
Tennessee NPs with full practice authority (granted after 1 to 3 years of supervised practice, depending on graduation year) can independently prescribe legend drugs including vardenafil. NPs practicing under a collaborative practice agreement with a physician can also prescribe vardenafil within the scope of that agreement.
Physician Assistants (PAs)
PAs in Tennessee prescribe vardenafil under a supervision agreement with a collaborating physician. The supervising physician does not need to be present at the time of prescribing, but the agreement must be on file with the Tennessee Board of Medical Examiners.
The AUA notes that primary care clinicians are appropriate first-line prescribers for ED in men without complex cardiovascular disease [4].
Step-by-Step: How to Get Vardenafil in Tennessee
Getting a prescription follows a predictable sequence whether done in person or via telehealth.
Step 1. Medical History and Intake
Your prescriber will ask about:
- Current medications, especially nitrates (nitroglycerin, isosorbide), alpha-blockers, and antihypertensives.
- Cardiovascular history: recent MI, unstable angina, significant arrhythmia.
- Liver or kidney disease (vardenafil is hepatically metabolized via CYP3A4; dose adjustment to 5 mg is recommended for moderate hepatic impairment per the FDA label) [5].
- Baseline blood pressure (hypotension risk is real at BP <90/50 mmHg).
- Use of CYP3A4 inhibitors such as ketoconazole, ritonavir, or clarithromycin, which can increase vardenafil exposure significantly.
Step 2. Labs (When Required)
Vardenafil does not require mandatory laboratory testing before prescribing. A thorough prescriber may order:
- Fasting glucose or HbA1c to screen for undiagnosed type 2 diabetes, which affects roughly 11 percent of U.S. Adults and is a major ED risk factor per CDC data [6].
- Total and free testosterone if hypogonadism is suspected (low testosterone reduces PDE5 inhibitor response in some patients) [7].
- Lipid panel and blood pressure measurement as cardiovascular risk screening.
- PSA if appropriate by age and guideline.
None of these labs delay the prescription for most healthy men seeking on-demand ED therapy. A prescriber may issue the prescription and request labs at the same visit.
Step 3. Prescription Issuance and Pharmacy Routing
Once the prescriber approves the prescription electronically, it routes to the pharmacy of your choice. Tennessee participates in the national e-prescribing infrastructure (Surescripts), so telehealth platforms can route to any Tennessee-licensed pharmacy. Standard generic vardenafil 10 mg or 20 mg tablets are stocked at major chains (CVS, Walgreens, Kroger, Walmart) and independent pharmacies across the state.
Step 4. Filling and Cost
Generic vardenafil is available for $1 to $4 per tablet with GoodRx-type discount programs at Tennessee pharmacies as of 2024. Without insurance or discount, retail cash price for 30 tablets of generic vardenafil 20 mg can reach $150 to $300. TennCare (Tennessee Medicaid) does not cover vardenafil for erectile dysfunction; coverage exists only in rare off-label cases involving a documented diagnosis where the formulary exception process succeeds [8].
Tennessee 503A Compounding Pharmacies and Vardenafil
Vardenafil is commercially available from multiple manufacturers as an FDA-approved drug, which places restrictions on compounding. However, 503A compounding pharmacies, those that compound for individual patient-specific prescriptions, may legally prepare vardenafil formulations that differ from commercially available products when a valid prescription exists and a legitimate clinical need is documented.
What 503A Compounding Means in Practice
A 503A pharmacy operates under state pharmacy board oversight plus FDA oversight for compounding standards. In Tennessee, the Board of Pharmacy licenses 503A pharmacies. A prescriber could write a patient-specific prescription for, say, a lower-dose vardenafil formulation or a specific tablet strength not commercially available. The pharmacy must compound in compliance with USP Chapter 795 standards for non-sterile preparations.
Shipping Rules
Tennessee-licensed 503A pharmacies may ship compounded vardenafil to a patient within Tennessee when a valid prescription is on file. Interstate shipping of compounded drugs from out-of-state pharmacies to Tennessee patients requires the out-of-state pharmacy to hold a Tennessee non-resident pharmacy license. Patients should verify licensure before using a mail-order compounding pharmacy.
Insurance, Prior Authorization, and TennCare Coverage
Most commercial insurance plans in Tennessee categorize PDE5 inhibitors as lifestyle drugs and exclude them from formulary coverage. Where coverage exists, prior authorization is almost always required.
What Prior Authorization Typically Requires
When a Tennessee insurer does cover vardenafil (usually under certain commercial plans), the prior authorization (PA) process typically requests:
- A written diagnosis of erectile dysfunction with ICD-10 code N52 (male erectile dysfunction) or a related sub-code.
- Documentation that the condition is not purely situational or psychological without organic component (depending on the plan).
- Prescriber attestation that the patient has no absolute contraindications.
- In some plans, evidence of failure or contraindication to a preferred formulary agent such as generic sildenafil (the cheapest PDE5 inhibitor in most formularies).
The PA process can take 3 to 10 business days. Patients should ask their prescriber's office to initiate PA at the time of the encounter if they want to pursue insurance coverage.
TennCare Specifics
TennCare, the Tennessee Medicaid managed care program, excludes vardenafil from coverage for erectile dysfunction across all its managed care organizations (BlueCare Tennessee, UnitedHealthcare Community Plan, Amerigroup). An exception exists on paper for cases where the drug is prescribed for a non-ED indication, but prescribers rarely encounter a clinically valid non-ED indication for vardenafil. Patients on TennCare should budget for out-of-pocket cost and use manufacturer coupons or pharmacy discount programs [8].
Transferring an Existing Vardenafil Prescription to Tennessee
If you move to Tennessee or wish to fill a prescription written by an out-of-state prescriber, the rules are straightforward. Vardenafil is a non-controlled legend drug. Tennessee pharmacies can accept a valid prescription from any U.S.-licensed prescriber and fill it, provided the prescription is not expired. A written prescription can also be transferred between pharmacies within Tennessee once, per Tennessee Board of Pharmacy rules. Electronic prescriptions routed through Surescripts can generally be redirected without issue.
If you relocate to Tennessee and need refills, you will need a Tennessee-licensed prescriber to write ongoing prescriptions unless the original prescriber holds a valid out-of-state Tennessee telehealth registration.
Safety Considerations Every Tennessee Patient Needs to Know
Absolute Contraindications
The FDA label for vardenafil carries a black-box-equivalent contraindication against co-administration with organic nitrates in any form [5]. This includes nitroglycerin tablets, nitroglycerin patches, isosorbide mononitrate, isosorbide dinitrate, and amyl nitrite (poppers). The combination can produce severe, life-threatening hypotension.
Cardiovascular Risk Stratification
The Princeton Consensus III (2012), a landmark multidisciplinary expert panel published in the American Journal of Cardiology, stratified patients into low, intermediate, and high cardiovascular risk before initiating PDE5 inhibitor therapy [9]. Low-risk patients (stable angina on medical management, controlled hypertension, asymptomatic mild valvular disease) may begin vardenafil without cardiology consultation. Intermediate- or high-risk patients require cardiac evaluation first.
Drug Interactions
- Alpha-blockers: Co-administration with tamsulosin or doxazosin requires dose reduction to vardenafil 5 mg and a 6-hour separation to reduce orthostatic hypotension risk.
- Strong CYP3A4 inhibitors: Ritonavir co-administration is contraindicated because it raises vardenafil AUC by up to 49-fold per pharmacokinetic studies [10].
- Moderate CYP3A4 inhibitors (ketoconazole 200 mg): Limit vardenafil to 5 mg per 24 hours per FDA label [5].
Side Effects
Common adverse events in clinical trials include headache (15 percent), flushing (11 percent), rhinitis (9 percent), and dyspepsia (4 to 6 percent) [1]. Rare but serious events include non-arteritic anterior ischemic optic neuropathy (NAION), sudden hearing loss, and priapism. Patients should seek emergency care for any erection lasting more than 4 hours.
Dosing Reference for Tennessee Prescribers and Patients
The FDA-approved dosing schedule for vardenafil is as follows [5]:
- Starting dose: 10 mg taken orally 30 to 60 minutes before sexual activity, not more than once per 24 hours.
- Titration: May increase to 20 mg or decrease to 5 mg based on response and tolerability.
- Hepatic impairment (moderate, Child-Pugh B): Start at 5 mg; do not exceed 10 mg.
- Renal impairment: No dose adjustment required for any degree of renal impairment per the label.
- Elderly (65 years and older): Consider a starting dose of 5 mg.
- Staxyn (orally disintegrating): 10 mg only; do not substitute for Levitra tablets on a mg-for-mg basis without prescriber review.
Staxyn is not bioequivalent to the standard tablet on a unit-dose basis. The FDA label notes that Staxyn 10 mg produces a higher Cmax than Levitra 10 mg because the orodispersible formulation bypasses first-pass metabolism to a slightly greater degree [5].
How Long Until You Receive Vardenafil in Tennessee?
Timeline depends on the access pathway.
- In-person visit, same-day fill: Same day. Most Tennessee retail pharmacies stock generic vardenafil and can fill within an hour of receiving the electronic prescription.
- Telehealth visit, retail pharmacy: Typically 24 to 48 hours from booking to pharmacy pickup, assuming same-day or next-day appointment availability.
- Telehealth visit, mail-order pharmacy: 3 to 7 business days for standard shipping; overnight shipping available from most mail-order pharmacies for an added fee.
- 503A compounded prescription: Allow 5 to 10 business days; compounding is patient-specific and requires preparation time.
If your clinical situation is straightforward and you have no disqualifying comorbidities, a telehealth platform serving Tennessee can often complete the intake, clinician review, and electronic prescription in under 2 hours on a business day.
Frequently asked questions
›How do I get a vardenafil (Levitra/Staxyn) prescription in Tennessee?
›What labs are needed before vardenafil in Tennessee?
›Are there telehealth providers in Tennessee prescribing vardenafil?
›How long until I receive vardenafil in Tennessee?
›Can I transfer a vardenafil prescription to Tennessee?
›Are 503A pharmacies in Tennessee licensed to ship vardenafil?
›Who can prescribe vardenafil in Tennessee (MD vs. NP vs. PA)?
›What documentation does prior authorization require in Tennessee?
›Does TennCare cover vardenafil for erectile dysfunction?
›Is vardenafil safe to take with blood pressure medication?
›What is the difference between Levitra tablets and Staxyn?
References
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2003;15(4):272-280. https://pubmed.ncbi.nlm.nih.gov/12834456/
- Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57(5):804-814. https://pubmed.ncbi.nlm.nih.gov/20189712/
- Bischoff E. Potency, selectivity, and consequences of nonselectivity of PDE inhibition. Int J Impot Res. 2004;16 Suppl 1:S11-14. https://pubmed.ncbi.nlm.nih.gov/15224129/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- U.S. Food and Drug Administration. Levitra (vardenafil hydrochloride) prescribing information. Bayer HealthCare Pharmaceuticals. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021368
- Centers for Disease Control and Prevention. National Diabetes Statistics Report. CDC; 2022. https://www.cdc.gov/diabetes/data/statistics-report/index.html
- Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: from basic research to a new clinical approach for managing men with androgen insufficiency and erectile dysfunction. Eur Urol. 2007;52(1):54-70. https://pubmed.ncbi.nlm.nih.gov/17335964/
- TennCare Bureau. Medicaid Preferred Drug List. Tennessee Department of Finance and Administration. https://www.tn.gov/tenncare/health-care-providers/tenncare-formulary.html
- Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96(2):313-321. https://pubmed.ncbi.nlm.nih.gov/16018863/
- Muirhead GJ, Wulff MB, Fielding A, Kleinermans D, Buss N. Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir. Br J Clin Pharmacol. 2000;50(2):99-107. https://pubmed.ncbi.nlm.nih.gov/10930958/